Follow
Enakshi D. Sunassee
Enakshi D. Sunassee
Verified email at duke.edu - Homepage
Title
Cited by
Cited by
Year
Proliferation saturation index in an adaptive Bayesian approach to predict patient-specific radiotherapy responses
ED Sunassee, D Tan, N Ji, R Brady, EG Moros, JJ Caudell, S Yartsev, ...
International journal of radiation biology 95 (10), 1421-1426, 2019
332019
An accessible laparoscope for surgery in low-and middle-income countries
JL Mueller, N Rozman, ED Sunassee, A Gupta, C Schuval, A Biswas, ...
Annals of biomedical engineering 49, 1657-1669, 2021
82021
Predicting patient-specific radiotherapy responses in head and neck cancer to personalize radiation dose fractionation
H Enderling, E Sunassee, JJ Caudell
Biorxiv, 630806, 2019
82019
Targeting tumor acidity with the LDHA inhibitor (FX11) and CAIX inhibitor (DH348) overcomes resistance to PD-1 blockade and inhibits metastasis in a pancreatic cancer model
AAI Hashim, D Abrahams, L Xu, B Centeno, E Sunassee, R Abddelgader, ...
Cancer Research 77 (13_Supplement), 5932-5932, 2017
82017
Adaptive Design of Fluorescence Imaging Systems for Custom Resolution, Fields of View, and Geometries
R Wang, RJ Deutsch, ED Sunassee, BT Crouch, N Ramanujam
BME Frontiers 4, 0005, 2023
72023
In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence
MC Madonna, JE Duer, BJ McKinney, ED Sunassee, BT Crouch, ...
NPJ Breast Cancer 8 (1), 111, 2022
42022
A Spectroscopic Technique to Simultaneously Characterize Fatty Acid Uptake, Mitochondrial Activity, Vascularity, and Oxygen Saturation for Longitudinal Studies In Vivo
RJ Deutsch, VW D’Agostino, ED Sunassee, M Kwan, MC Madonna, ...
Metabolites 12 (5), 369, 2022
32022
Metabolic Imaging as a Tool to Characterize Chemoresistance and Guide Therapy in Triple-Negative Breast Cancer (TNBC)
ED Sunassee, BV Jardim-Perassi, MC Madonna, B Ordway, ...
Molecular Cancer Research, MCR-22-1004, 2023
22023
Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence
ED Sunassee, RJ Deutsch, VW D’Agostino, P Castellano-Escuder, ...
Science Advances 10 (14), eadj7540, 2024
2024
Development of a multi-scale imaging tool to quantify in vivo metabolic heterogeneity
ED Sunassee, RJ Deutsch, MC Madonna, BT Crouch, N Ramanujam
Multiscale Imaging and Spectroscopy V 12827, 17-19, 2024
2024
In Vivo Metabolic Imaging Reveals Mitochondrial Membrane Potential Reprogramming During Residual Disease Following Chemotherapy
ED Sunassee, B Crouch, M Madonna, G Palmer, N Ramanujam
Optical Molecular Probes, Imaging and Drug Delivery, OW1E. 4, 2023
2023
Development of a multi-scale platform to quantify metabolic heterogeneity in vivo
RJ Deutsch, R Wang, ED Sunassee, MC Madonna, BT Crouch, ...
Optical Molecular Probes, Imaging and Drug Delivery, OW1E. 3, 2023
2023
Abstract P6-01-01: Validation of an Optical Imaging Platform to Identify Metabolic Vulnerabilities in Chemo-Resistant and Sensitive Tumors
ED Sunassee, E Maydew, B Crouch, M Madonna, GM Palmer, ...
Cancer Research 83 (5_Supplement), P6-01-01-P6-01-01, 2023
2023
Optical imaging captures chemo-induced metabolic reprogramming during disease regression
ED Sunassee, E Maydew, S Erturk, M Madonna, B Crouch, N Ramanujam
Cancer Research 82 (12_Supplement), 2465-2465, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–14